Moreover, through collaborating with c-KIT, knocking down lncRNA CCDC26 and overexpressing lncRNA RP11-616M22.7 increased the resistance of GIST cells to imatinib (Cao K. et al., 2018; Shao et al., 2021). Here, KIT is linked to gastrointestinal stromal tumor.